At TLC, we develop novel nanomedicines that maximize the potential of our lipid-based drug delivery technologies. We are currently focused on creating new therapies in the areas of oncology, ophthalmology and osteoarthritis.

Industries

Employees

51-200

Links


Org chart

Keelung Hong
Founder, Chairman & CEO
Collapse
George Yeh
President
George Spencer-Green
Chief Medical Officer
Paige Tsai
Director, Human Resources


Offices